News

Gilead Sciences Enhances Partnership with Veeva Vault CRM

Gilead Sciences Enhances Partnership with Veeva Vault CRM

Gilead Sciences and Veeva Systems Partnership

Gilead Sciences is taking a significant step forward in the realm of customer relationship management by committing to Veeva Vault CRM, a next-generation tool designed to streamline commercial operations. This state-of-the-art system harnesses deep capabilities and agentic AI, ensuring Gilead remains a frontrunner in the biopharmaceutical sector.

Why the Shift to Vault CRM?

Peter Gassner, CEO of Veeva Systems, expressed pride in extending their strategic partnership with Gilead, stating, "Gilead is a leader in life-changing medicines and has been a pioneer of major scientific advancements in virology, inflammation, and oncology." The Vault CRM platform promises to enhance operational efficiency and effectiveness, ensuring that Gilead's team can spend more time focusing on patient care rather than getting bogged down in administrative tasks.

Benefits of Veeva Vault CRM

With Vault CRM, Gilead will utilize advanced AI capabilities, including pre-call planning, compliant free text, and voice control features to maximize commercial performance. The aim is to streamline processes, enhance collaboration, and ultimately lead to better patient outcomes through more efficient communications.

Gilead's Role in Patient Care

Gilead Sciences has been at the forefront of developing innovative medicines to address life-threatening diseases such as HIV, viral hepatitis, COVID-19, and various cancers. The company is actively committed to advancing healthcare solutions that cater to the needs of patients worldwide.

Expanding Partnership

Anna Åsberg, Gilead's Global CIO, highlighted the excitement surrounding the transition to Vault CRM. She noted, "We are excited to expand our long-standing partnership with Veeva by moving to Vault CRM. We share a deep commitment to advancing medicine and are excited to explore the potential of Veeva AI to help drive commercial execution to the next level." This sentiment reflects Gilead's unwavering dedication to innovation in healthcare.

The Future of Medicine with AI

This partnership signifies a broader trend within the biopharmaceutical industry: the increasing utilization of artificial intelligence to enhance operational practices. AI is transforming how companies interact with healthcare professionals and manage their information, thus generating insights that enhance patient relationships.

About Veeva Systems

Veeva delivers a comprehensive cloud ecosystem tailored for life sciences, focusing on leveraging software, data, and consulting services to help clients meet their commercial needs. With over 1,500 customers, Veeva stands as a key player in the industry, helping organizations enhance their operational efficiency.

About Gilead Sciences

Gilead Sciences, Inc. is not just a biopharmaceutical company; it has been a beacon of innovation dedicated to creating a healthier world for all. Operating in over 35 countries, Gilead is committed to advancing therapeutic options for diseases affecting millions globally.

Commitment to Stakeholders

As a company committed to innovation and collaboration, Gilead remains focused on the interests of its stakeholders, including customers, employees, and the broader community. With its integration of Veeva Vault CRM, Gilead demonstrates its ongoing commitment to utilizing cutting-edge technology in its mission to improve patient health.

Frequently Asked Questions

What is Veeva Vault CRM?

Veeva Vault CRM is a next-generation customer relationship management system designed for the life sciences industry, offering advanced AI capabilities for better commercial execution.

Why is Gilead moving to Veeva Vault CRM?

Gilead is moving to Veeva Vault CRM to enhance operational efficiency, streamline processes, and leverage AI to improve patient interactions and commercial strategies.

What does the partnership mean for Gilead?

This partnership allows Gilead to expand its capabilities in managing customer relationships, ultimately benefiting their operational strategies and enhancing patient outcomes.

How long has Gilead had a relationship with Veeva?

Gilead has a long-standing relationship with Veeva Systems, which is being strengthened through the integration of Vault CRM.

What types of diseases does Gilead focus on?

Gilead is dedicated to treating life-threatening diseases such as HIV, viral hepatitis, COVID-19, cancer, and inflammation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 1

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
VEVOR Unveils New Products at IFA Berlin 2026

Updated Category News Views 3

VEVOR's Bold Display at IFA Berlin VEVOR isn't shy about making waves at IFA Berlin 2026. The global home improvement heavyweight decided to go all out with an interactive booth that's hard to miss, giving visitors a real taste—sometimes literally—of what they’ve got to offer. This hands-on approach isn't just a gimmick; it’s a clever move to solidify VEVOR's...

Continue Reading
FOTON Accelerates Global Push with European Focus

Updated Category News Views 4

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

Continue Reading
Chef André Chiang Reimagines A Joy's Autumn Menu

Updated Category News Views 3

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 1

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Yas Island's Bold Move: Expanding With Potter Magic

Updated Category News Views 4

Potter Magic Takes Over Warner Bros. World Abu Dhabi Call it a stroke of wizardry or plain savvy business sense, Miral and Warner Bros. Discovery Global Experiences are betting large on Harry Potter with a trio of themed lands at Warner Bros. World Abu Dhabi. Brace yourselves, because this ain't your mother's theme park nostalgia—this is about breathing new life into a...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 1

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 1

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading

Top 5 Most Recently Viewed Articles

Remcom Secures NASA Contract for Advanced Wireless Simulation Tech

Updated Category News Views 176

Remcom Secures NASA Contract for Innovative Wireless Simulation Remcom has taken a significant leap forward by securing a Small Business Innovation Research (SBIR) Phase I contract from NASA. This partnership aims to enhance wireless channel modeling for antennas utilized in astronaut spacesuits and lunar vehicles, crucial for effective communication during lunar...

Continue Reading
Empowering Patients: New Kidney Cancer Campaign Launch by AKF

Updated Category News Views 313

American Kidney Fund Launches Educational Campaign on Kidney Cancer The American Kidney Fund (AKF) is excited to announce the launch of a pivotal educational campaign focusing on kidney cancer, precisely timed ahead of World Kidney Cancer Day. This initiative aims to empower patients, families, and caregivers with valuable information and support regarding kidney cancer,...

Continue Reading
Valneva SE Under Investigation: What Investors Need to Know

Updated Category News Views 185

Valneva SE Faces Serious Investigations Valneva SE, a biotech company specializing in developing innovative vaccines, is currently under scrutiny following serious claims directed at its management team. The concerns revolve around possible securities fraud and other unlawful business practices, sparking interest from investors and analysts alike. Impact of CDC...

Continue Reading
Molina Healthcare, Inc. Under Legal Fire: Investor Information Inside

Updated Category News Views 179

Molina Healthcare, Inc. Faces Legal Challenges Molina Healthcare, Inc. (NYSE:MOH) is currently embroiled in a securities class action lawsuit following a significant decline in its stock price. This situation has drawn the attention of investors who may have been affected by the company's recent performance and the allegations made against it. What Caused the Stock Drop?...

Continue Reading
Investor Class Action Updates: DeFi Technologies and Blue Owl

Updated Category News Views 207

Important Class Actions for Investors Class actions have been initiated, drawing attention to the investment landscapes involving key players in the financial and tech sectors. Investors holding shares in both DeFi Technologies Inc. (NASDAQ: DEFT) and Blue Owl Capital Inc. (NYSE: OWL) should be aware of upcoming legal deadlines and their rights. DeFi Technologies:...

Continue Reading